Tumor Marker Testing Program: Monitoring Cancer Markers

At DeMaster, we understand the importance of early detection and monitoring of cancer markers to facilitate timely intervention and treatment. Our Tumor Marker Testing Program offers comprehensive monitoring of tumor markers, including Alpha-fetoprotein (AFP), to aid in the detection and management of various types of cancers. 

  

What is AFP? 

  

Alpha-fetoprotein (AFP) is a tumor marker that is normally produced by the epithelium of the egg sac (yolk sac), liver cells, and the digestive tract during fetal development. Elevated levels of AFP can indicate certain types of cancers, particularly liver cancer (hepatocellular carcinoma), ovarian cancer, testicular cancer, and embryonal cell carcinoma. 

  

Our Testing Program:  

1. Early Detection: Our program includes regular testing of AFP levels in high-risk populations, such as individuals with chronic hepatitis, hepatitis B carriers, and cirrhosis patients. Early detection of elevated AFP levels can prompt further diagnostic evaluations to detect cancer at its earliest stages. 

2. Monitoring: We offer regular monitoring of AFP levels through repeated testing every 3 to 6 months, as recommended by medical guidelines. This ongoing monitoring helps track changes in AFP levels over time and provides valuable information about disease progression and treatment response.   

3. Complementary Imaging: In addition to AFP testing, our program may recommend complementary imaging studies, such as ultrasound examinations of the liver, to further assess for the presence of cancer or other liver diseases.   

4. Personalized Care: Our team of experienced medical professionals provides personalized care and guidance throughout the testing process, ensuring that each patient receives tailored recommendations based on their individual risk factors and medical history. 

  

By participating in our Tumor Marker Testing Program, you can take proactive steps towards early detection, monitoring, and management of cancer. Schedule your consultation today to learn more about how our program can support your health and well-being. 

DeMaster offers a Tumor Marker Testing Program focusing on early detection and monitoring of cancer through AFP level testing. It includes regular testing for high-risk populations, ongoing AFP monitoring, complementary imaging, and personalized care, aiding in timely cancer detection and management.